Stay updated with breaking news from Atacand Plus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AstraZeneca PLC (LON:AZN – Get Free Report) has earned a consensus rating of “Moderate Buy” from the nine ratings firms that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and eight have issued a buy rating on the company. The average 1-year target price […]
US Bancorp DE grew its position in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 10.2% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 155,377 shares of the company’s stock after purchasing an additional 14,324 shares during the quarter. US Bancorp DE’s […]
Morgan Stanley initiated coverage on shares of AstraZeneca (NASDAQ:AZN – Free Report) in a research report report published on Tuesday, Marketbeat Ratings reports. The firm issued an overweight rating on the stock. AZN has been the subject of several other research reports. Jefferies Financial Group downgraded shares of AstraZeneca from a buy rating to a […]
EverSource Wealth Advisors LLC decreased its stake in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 9.7% in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 5,542 shares of the company’s stock after selling 593 shares during the quarter. EverSource Wealth Advisors LLC’s holdings in […]
Syon Capital LLC bought a new stake in AstraZeneca PLC (NASDAQ:AZN – Free Report) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 16,011 shares of the company’s stock, valued at approximately $1,084,000. Other hedge funds also recently added to or reduced their stakes in […]